NCT05538897 · Interventional trial
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
Overall registry status Active not recruiting
Phase 1 · Phase 2
Conditions FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic Endometrial Endometrioid Adenocarcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma
Delaware Valley sites
- Asplundh Cancer Pavilion · Willow Grove, PA · Montgomery County
- Cooper Hospital University Medical Center · Camden, NJ · Camden County
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory